These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35634869)

  • 1. Implementation of supervised physical training to reduce vasovagal syncope recurrence: A randomized controlled trial.
    Aghajani F; Tavolinejad H; Sadeghian S; Bozorgi A; Jalali A; Vasheghani-Farahani A; Yadangi S; Niazi S; Poopak A; Tajdini M
    J Cardiovasc Electrophysiol; 2022 Aug; 33(8):1863-1870. PubMed ID: 35634869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
    Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
    Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tilt training: does it have a role in preventing vasovagal syncope?
    Gurevitz O; Barsheshet A; Bar-Lev D; Zimlichman E; Rosenfeld GF; Benderly M; Luria D; Amital H; Kreiss Y; Eldar M; Glikson M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1499-505. PubMed ID: 18070305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A
    Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    Baron-Esquivias G; Morillo CA; Moya-Mitjans A; Martinez-Alday J; Ruiz-Granell R; Lacunza-Ruiz J; Garcia-Civera R; Gutierrez-Carretero E; Romero-Garrido R
    J Am Coll Cardiol; 2017 Oct; 70(14):1720-1728. PubMed ID: 28958328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database.
    Russo V; Rago A; De Rosa M; Papa AA; Simova I; Petrov I; Bonev N; Gargaro A; Golino P; Nigro G
    Int J Cardiol; 2018 Nov; 270():149-153. PubMed ID: 29980368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
    Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
    J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.
    Sutton R; Brignole M; Menozzi C; Raviele A; Alboni P; Giani P; Moya A
    Circulation; 2000 Jul; 102(3):294-9. PubMed ID: 10899092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
    Ammirati F; Colivicchi F; Santini M;
    Circulation; 2001 Jul; 104(1):52-7. PubMed ID: 11435337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors.
    Zeng H; Ge K; Zhang W; Wang G; Guo L
    Int Heart J; 2008 Nov; 49(6):707-12. PubMed ID: 19075486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).
    van Dijk N; Quartieri F; Blanc JJ; Garcia-Civera R; Brignole M; Moya A; Wieling W;
    J Am Coll Cardiol; 2006 Oct; 48(8):1652-7. PubMed ID: 17045903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
    Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
    Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result.
    Malik P; Koshman ML; Sheldon R
    J Am Coll Cardiol; 1997 May; 29(6):1284-9. PubMed ID: 9137225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of vasovagal syncope recurrence in children and adolescents and value of head-up tilt table test.
    Tanrıverdi Yılmaz S; Binnetoğlu K; Babaoğlu K; Altun G
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):688-94. PubMed ID: 23996804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis after tilt training in patients with recurrent vasovagal syncope.
    Jang WJ; Yim HR; Lee SH; Park SJ; Kim JS; On YK
    Int J Cardiol; 2013 Oct; 168(4):4264-5. PubMed ID: 23642601
    [No Abstract]   [Full Text] [Related]  

  • 20. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI.
    Sheldon RS; Lei L; Guzman JC; Kus T; Ayala-Paredes FA; Angihan J; Safdar S; Maxey C; Bennett G; Raj SR
    Europace; 2019 Nov; 21(11):1733-1741. PubMed ID: 31538180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.